جست‌وجوی استاد و پژوهشگر

• Cancer Biology
• Molecular Oncology
• Tumor Suppression
• +۷ مورد دیگر

Yousef G. Amaar, PhD is an Assistant Research Professor in the General Surgery Division of the School of Medicine at Loma Linda University. His academic career spans over three decades with a focus on cancer biology and molecular mechanisms of tumor development. Education: PhD from Simon Fraser University (1997) Dr. Amaar's research primarily focuses on the RASSF1 gene family, particularly the RASSF1C isoform, and its role in cancer development and progression. His work has extensively explored how RASSF1C interacts with various molecular pathways including PIWIL1, DNA methylation, and microRNA regulation in lung and breast cancer. Earlier in his career, he also conducted significant research on osteoblast differentiation and insulin-like growth factor binding proteins. Analysis of Dr. Amaar's publication record from the last two decades reveals a clear research trajectory centered on cancer biology, particularly focusing on the RASSF1C protein's role in tumor development. His work demonstrates how RASSF1C influences key cancer processes including cell proliferation, apoptosis, epithelial-mesenchymal transition, and DNA methylation. His research has spanned multiple cancer types, with particular emphasis on lung and breast cancers, and has explored connections between RASSF1C and various molecular pathways including PIWIL1, IGFBP-5, and microRNA networks. Dr. Amaar has collaborated extensively with Dr. Reeves and other researchers at Loma Linda University, contributing to numerous publications in reputable journals such as Oncotarget, PLoS ONE, and the Journal of Bone and Mineral Research. His work has been consistently funded through institutional support and likely external grants, though specific grant details are not provided in the available information. While specific laboratory details are not extensively documented in the provided information, Dr. Amaar appears to lead or be a significant contributor to a research team focused on molecular cancer biology, particularly investigating the mechanisms by which RASSF1C influences tumor development and progression.

• Molecular Biology
• Diabetes Genetics
• Sports Health
• +۲ مورد دیگر

Professor Lise Bjørkhaug Gundersen works at the Western Norway University of Applied Sciences , affiliated with the Department of Safety, Chemistry and Biomedical Laboratory Sciences . She specializes in molecular biology research focusing on the genetic mechanisms underlying diabetes and sports performance biomarkers. Teaches Pathology at bachelor level Coordinates courses in Medical Laboratory Technology and Advanced Biomedical Analytical Methods Member of the BIOMARG multidisciplinary research group Her research spans: Inherited (monogenic) diabetes and genetic factors Type 2 diabetes genetic susceptibility Sports health biomarkers and performance genetics Recent publications demonstrate expertise in: HNF1A/HNF4A gene variant characterization microRNA responses to exercise Polygenic risk analysis across populations

Andrea Baccarelliمشاهده پروفایل

استاد

• Environmental Health
• Air Pollution
• DNA Methylation
• +۵ مورد دیگر

Andrea Baccarelli is the Dean of the Faculty and a Professor of Environmental Health at the Harvard T.H. Chan School of Public Health. His research focuses on the intersection of environmental exposures and human health, particularly examining how air pollution, metals, and climate factors influence aging, maternal-child outcomes, and chronic disease. His work involves extensive NIH-funded projects on topics including: Prenatal Traffic-Related Air Pollutants and Child Cognition Extracellular Vesicles in Aging Studies Epitranscriptomic Mechanisms of Arsenic-Induced Diabetes Maternal Obesity Risks from Particulate Pollution Key research areas include DNA Methylation , Environmental Epidemiology , and Extracellular Vesicle Biology . His recent publications highlight collaborations across 1120 concepts with 135 co-authors, including Joel Schwartz and Petros Koutrakis. He is actively involved in public health education initiatives, including the development of intensive short-term courses for health professionals.

• Cardiovascular Physiology
• Hypertension
• Cardiac Remodeling
• +۶ مورد دیگر

Frederic Michel is an Associate Professor in the Department of Physiology at the University of the Witwatersrand (Wits), South Africa. He holds a PhD from Paris and has been actively involved in cardiovascular research, particularly focusing on hypertension, cardiac remodeling, and vascular pathophysiology. Education: PhD – University of Paris Research Focus: His research integrates molecular, physiological, and translational approaches to understand the mechanisms underlying hypertension and cardiovascular disease. Key areas include the role of microRNAs in cardiac remodeling, sex-specific responses to adrenergic stress, the renin-angiotensin system, and the impact of dietary and hormonal factors on vascular and cardiac function. His work often employs animal models such as spontaneously hypertensive rats and community-based human cohorts, particularly among populations of African ancestry. Scientific Contributions: Dr. Michel has authored numerous peer-reviewed articles in high-impact journals such as Circulation , Hypertension , and the American Journal of Physiology . His work has significantly advanced understanding of how adipokines like resistin, dietary salt, and sex hormones influence cardiovascular structure and function. His recent studies explore the therapeutic potential of natural compounds like quercetin and the diagnostic utility of urinary angiotensinogen as a biomarker for hypertension.

• Pharmacogenomics
• Drug Metabolism
• Cancer Pharmacology
• +۴ مورد دیگر

Henrike Bruckmüller is an Associate Professor at UiT The Arctic University of Norway, actively contributing to the Cell Signalling and Targeted Therapy research group and the project Role of DUSP2 in cancer cell signaling in hematological malignancies . Her research focuses on: Pharmacogenomics : Genetic variants in drug transporters (ABCB1, ABCG2) and metabolizing enzymes affecting drug response Cancer Pharmacology : Mechanisms of tyrosine kinase inhibitor resistance in chronic myeloid leukemia (CML) Neuropathic Pain : Genetic associations in serotonin and sigma-1 receptor pathways Herbal-Drug Interactions : Impact of phytocompounds on efflux transporters Her 15 most recent publications (2017-2024) reveal consistent themes: genomic analysis of drug resistance mechanisms, microRNA regulation in cancer, and pharmacogenomic determinants of pain sensitivity. Methodologically, her work integrates exome sequencing, transcriptomics, and functional transporter assays to advance precision medicine. No specific scientific awards are documented in available sources. Information regarding student mentorship and research grants is not publicly disclosed in the provided materials. She maintains active roles in the Cell Signalling and Targeted Therapy research group and the DUSP2 hematological malignancies project, based at UiT's Tromsø campus.

• Rheumatology
• Immunology
• Genetics
• +۳ مورد دیگر

Professor Liye Chen serves as a Career Development Fellow funded by Versus Arthritis and Principal Investigator at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science (NDORMS), University of Oxford. He leads the Chen group focused on Human Immunology in Inflammation, collaborating with Professor Paul Bowness and Professor Richard Williams. His medical training was completed at HuaZhong University of Science and Technology, followed by a Versus Arthritis-funded PhD (2009-2013) at the University of Oxford under Paul Bowness. Chen's research centers on immunogenetics of rheumatic diseases, particularly Ankylosing Spondylitis (AS). His seminal work elucidated HLA-B*27/ERAP1 interactions in antigen presentation, identified novel Th17-regulating microRNAs and epigenetic regulators (BRPF1/2), and defined unique T-cell phenotypes in AS patients. He pioneers genetics-led immunological interrogation to discover therapeutic targets for immune-mediated diseases, integrating molecular immunology with translational approaches. His publication portfolio demonstrates consistent focus on spondyloarthritis pathogenesis, HLA immunobiology, and therapeutic target validation, with increasing integration of computational methods for drug discovery across immune disorders. Key scientific recognition includes: Versus Arthritis PhD Fellowship Versus Arthritis Career Development Fellowship As Principal Investigator, Chen directs Versus Arthritis-funded research programs investigating genetic mechanisms of inflammatory arthritis. His group leverages human immunology approaches to translate genetic associations into biological mechanisms and therapeutic opportunities, with emphasis on T-cell immunology and antigen presentation pathways. The Chen group operates within NDORMS' Human Immunology in Inflammation research theme, maintaining active collaboration with the Kennedy Institute of Rheumatology and utilizing resources from the ULTRA-DD consortium for target validation in spondyloarthritis.

Alex Manicardiمشاهده پروفایل

دانشیار

• Organic Chemistry
• Bio-Organic Chemistry
• Peptide Nucleic Acids (PNA)
• +۵ مورد دیگر

Alex Manicardi is an Associate Professor in the Department of Chemical, Life and Environmental Sustainability Sciences at the University of Parma's Faculty of Chemistry. His academic responsibilities span multiple degree programs including Biotechnology, Materials Science, Chemistry, and Environmental and Resource Sciences, where he teaches core courses in organic chemistry, bio-organic chemistry, materials-focused chemistry, and chemical safety across undergraduate and graduate levels. Professor Manicardi's research program centers on peptide nucleic acid (PNA) engineering for nucleic acid targeting and therapeutic applications. His laboratory develops innovative chemical tools including furan-modified PNAs, photo-inducible crosslinking systems, and proximity-triggered ligation methodologies. This work bridges synthetic organic chemistry with biomedical challenges in cancer therapy (particularly colorectal cancer and glioblastoma) and genetic disorders like cystic fibrosis, focusing on microRNA modulation and sequence-specific DNA/RNA targeting. Analysis of his 15 most recent publications reveals a clear trajectory from fundamental chemical methodology development toward biomedical translation. Key trends include red light-triggered DNA alkylation for G-quadruplex targeting, microRNA-inhibiting PNAs that induce cancer cell apoptosis, and furan-based systems enabling bio-orthogonal ligation. The research demonstrates strong interdisciplinary integration across organic chemistry, chemical biology, and molecular oncology with significant therapeutic implications.

Nick Colemanمشاهده پروفایل

استاد

• Cancer diagnosis
• Molecular pathology
• Cervical cancer
• +۷ مورد دیگر

Professor Nick Coleman is Professor of Molecular Pathology at the University of Cambridge, Head of the Division of Cellular and Molecular Pathology, and a Fellow in Medicine at Downing College holding the Verjee Fellowship. His research focuses on translating molecular discoveries into improved cancer diagnostics and management. His primary research areas include: Mechanisms of cervical neoplastic progression using the W12 cervical keratinocyte model Therapeutic targets in squamous cell carcinoma, particularly oncostatin M receptor (OSMR) Malignant germ cell tumors and pediatric cancers with emphasis on microRNA biomarkers Development of novel cancer diagnostic approaches through molecular pathology Professor Coleman's publications reveal a consistent focus on HPV-related cervical cancer mechanisms, OSMR as a therapeutic target, and microRNA biomarkers for pediatric cancers. His group maintains extensive tissue archives and utilizes advanced molecular cytogenetic techniques including chromosome microdissection for identifying translocation breakpoints. Scientific recognition: Fellow of the Academy of Medical Sciences (FMedSci) Professor Coleman mentors numerous PhD students and leads a national translational study on germ cell tumors approved by the UK Children's Cancer and Leukaemia Group. His laboratory has discovered that microRNAs from the miR-371~373 and miR-302/367 clusters serve as universal biomarkers for malignant germ cell tumors, enabling development of serum-based diagnostic tests for childhood cancers. Current work focuses on translating these findings into clinical protocols for cancer diagnosis, prognostication, and monitoring. His research group operates within Cambridge's Department of Pathology, collaborating closely with Professor Margaret Stanley on cervical cancer mechanisms and developing minichromosome maintenance (MCM) proteins as markers for identifying malignant and pre-malignant cells in various clinical samples.

Adrian Listonمشاهده پروفایل

استاد

• Immunology
• Neuroimmunology
• Regulatory T cells
• +۵ مورد دیگر

Adrian Liston is Professor of Pathology at the University of Cambridge's Department of Pathology, Honorary Group Leader at the Babraham Institute, and Professorial Fellow at St Catharine's College where he serves as Postgraduate Tutor for Welfare, Equalities Fellow, and Director of Studies. He holds additional roles as Editor-in-Chief of Immunology & Cell Biology. His education includes: BSc (Biomedical Science) and Honours from Adelaide University PhD from Australian National University Post-doctoral training at University of Washington Graduate Certificate in Higher Education Master of Public Health MA from University of Cambridge Liston's research focuses on decoding immune system regulation, particularly the role of regulatory T cells in tissue homeostasis. His laboratory investigates cellular control mechanisms governing immune tolerance switches and how defects lead to pathologies including autoimmunity, diabetes, and neuropathology. The Liston-Dooley Lab employs mouse models, human samples, and cutting-edge techniques like high-dimensional flow cytometry to identify common pathways to pathology across disease states. His publications demonstrate consistent focus on neuroimmunology, tissue-resident immunity, and translational applications. Recent work emphasizes brain-specific regulatory T cell modulation, microglial biology, and gut-immune interactions. The lab maintains strong methodological innovation in flow cytometry and computational immunology. Major scientific honors include: Fellowship of Academy of Medical Sciences (2021) Fellowship of Royal Society of Biology (2022) ERC Consolidator Award (2016) Eppendorf Award for Young European Investigators (2016) Francqui Foundation Chair (2016) Wellcome Trust Investigator Award Liston directs the Liston-Dooley Laboratory with Dr. James Dooley, focusing on regulatory T cell-tissue interfaces. The lab relocated to Cambridge in 2023 after establishing core facilities at VIB/University of Leuven (2009-2018) and conducting neuroinflammation biotechnology research at Babraham Institute (2019-2023). They founded spin-off company Aila Biotech Ltd to develop neuroimmunology therapies. Notable alumni include Professors Susan Schlenner, Stephanie Humblet-Baron, Lidia Yshii, Kailash Singh, and Emanuela Pasciuto.

Stephen D. Ginsbergمشاهده پروفایل

استاد

• Molecular Neuroscience
• Cellular Neuroscience
• Translational Neuroscience
• +۶ مورد دیگر

Stephen D. Ginsberg, PhD, is a Professor in both the Department of Psychiatry and Department of Neuroscience at NYU Grossman School of Medicine. His research focuses on molecular and cellular mechanisms underlying neurodegenerative disorders, particularly Alzheimer's disease and Down syndrome. PhD from Mount Sinai School of Medicine Fellowship at Johns Hopkins University School of Medicine (Division of Neuropathology) Fellowship at University of Pennsylvania School of Medicine (Center for Neurodegenerative Disease Research) His work integrates digital spatial profiling , single-cell transcriptomics , and proteomics to study neuronal subtypes, gene expression mosaics, and connectivity-based degeneration patterns. Recent publications examine microRNA dysregulation, cholinergic mechanisms in Alzheimer's disease, and systems-level protein interaction dysfunction. Current affiliations include NYU Langone Health, where he investigates neurodegenerative pathogenesis and translational neuroscience . His laboratory develops computational platforms like dfPPI for analyzing protein-protein interaction networks in disease states.

Sepanta Hosseinpourمشاهده پروفایل

عضو هیئت علمی

• Tissue Engineering
• Regeneration
• Endodontics
• +۳ مورد دیگر

Dr. Sepanta Hosseinpour is a Clinical Lecturer at the University of Queensland's School of Dentistry and a Fellow of the UK Higher Education Academy. He holds a Doctorate of Dental Surgery (DDS) and Master of Public Health (MPH) from Shahid Beheshti University of Medical Sciences and completed his PhD in tissue regeneration at UQ in 2023. DDS, Shahid Beheshti University of Medical Sciences MPH, Shahid Beheshti University of Medical Sciences PhD, University of Queensland (2023) His research spans tissue engineering, regeneration, endodontics, and nanotechnology , focusing on mesoporous silica nanoparticles for bone repair, immunomodulatory dental biomaterials, and evidence-based dentistry. He has published over 40 papers and a book on regenerative dentistry. Recent works (2023-2025) highlight his expertise in dental biomaterials, nanoparticle delivery systems, and osteoimmunomodulation , with systematic reviews on platelet-rich products and clinical risk assessments of 3D-printed scaffolds. Fellow, UK Higher Education Academy As an affiliate lecturer at ITaLI , he develops teaching innovations. His supervision includes PhD work on macrophage regulation via nano-bio interactions. Current grants (2024-2026) focus on next-generation endodontic biomaterials with the Australian Society of Endodontology Inc. He collaborates with Professor Saso Ivanovski in bone tissue engineering and has contributed to projects involving smart scaffolds, photobiomodulation, and dental stem cell differentiation .

Amanda Garnerمشاهده پروفایل

استاد

• Medicinal Chemistry
• RNA Biology
• Cancer Therapeutics
• +۳ مورد دیگر

Amanda Garner is a Professor in the Department of Medicinal Chemistry at the University of Michigan , focusing on RNA biology and cancer therapeutics. Her work centers on targeting RNA-binding proteins (RBPs) and translation regulation mechanisms, particularly eIF4E, which plays a critical role in oncogenic protein synthesis. Research Themes: eIF4E inhibition, RNA-protein interactions, mRNA cap analogs, and translational control in cancer. Collaborations: Active partnerships with researchers like Emilio L Cárdenas, Jeanne Stuckey, and Vibha Lama. Recent studies explore CRISPR-based screening for RNA-protein interactions, second-generation prodrugs for cancer therapy, and neuroprotective roles of αA-crystallin. She also contributes to diversity initiatives in medicinal chemistry through the ACS Division.

• HIV Prevention
• Virology
• Immunology
• +۴ مورد دیگر

Michel Alary is an Associate Professor at Laval University's Faculty of Medicine. He conducts research at the Research Center of the CHU de Québec - Université Laval, focusing on HIV prevention and immunology. His work spans epidemiology, microbiology-immunology, and public health interventions. His research explores HIV replication mechanisms Immune system responses in exposed populations Extracellular vesicle dynamics in HIV patients Public health strategies like pre-exposure prophylaxis (PrEP) Recent publications analyze biomarkers in HIV pathogenesis and prevention efficacy across West Africa. Supervision includes doctoral and master's students in epidemiology and microbiology-immunology. Email: michel.alary@fmed.ulaval.ca

Radheshyam Tewariمشاهده پروفایل

استاد آموزشی

• Quality Engineering
• Lean Manufacturing
• Mechanical Micromachining
• +۹ مورد دیگر

Radheshyam Tewari is a Teaching Professor in the Mechanical and Aerospace Engineering (MAE) department at Michigan Technological University . He earned his PhD and MS in Mechanical Engineering from Michigan Tech and holds a BS in Mechanical Engineering from Maulana Azad National Institute of Technology, India. PhD, Michigan Technological University MS, Michigan Technological University BS, Maulana Azad National Institute of Technology, India Tewari's research spans interdisciplinary domains including implantable medical devices , micro- and nano-biosensors , micromachining , and semiconductor fabrication . His recent publications focus on education research , biomedical device manufacturing , and microfluidics . Notably, he coordinates the MAE Graduate Seminar Series , emphasizing cross-disciplinary knowledge sharing. Scientific contributions include work on graphene-based biosensors , PLA packaging for implants , and microfabrication processes . His teaching expertise encompasses quality engineering , six-sigma , design of experiments , and sustainable manufacturing .

Steven Hicksمشاهده پروفایل

استاد

• Molecular biomarkers
• Autism spectrum disorder diagnostics
• microRNA research
• +۴ مورد دیگر

Steven Hicks, MD, PhD is a Professor in the Department of Pediatrics, Division of Academic General Pediatrics at Penn State College of Medicine. He serves as director of the Pediatric Clinical Research Office and is affiliated with the Penn State Neuroscience Institute. His translational research focuses on identifying molecular biomarkers that inform child growth, neurodevelopment and disease. Education: Residency, SUNY Upstate Medical University (2015) MD, SUNY Upstate Medical University (2012) PhD, SUNY Upstate Medical University (2012) BS, Marist College (2005) Dr. Hicks' research spans three primary areas that intersect molecular biology and pediatric medicine. His autism spectrum disorder work has identified alterations in the oral microbiome and microtranscriptome that aid early diagnosis, resulting in a CLIA-certified diagnostic aid in 2019. His breastmilk micro-transcriptomics research explores how non-coding RNA factors impact infant health outcomes like weight gain. His concussion research investigates salivary microRNA profiles for traumatic brain injury management, featured in NPR, CBS News, and named among the "10 Most Talked About JAMA Peds Articles of 2018". Dr. Hicks' scholarly contributions demonstrate consistent translation of molecular discoveries into clinical applications, with research published in high-impact journals including JAMA Pediatrics, Autism Research, and Frontiers in Genetics. Scientific Awards: Department of Pediatrics Top Educator Award (2016) Graduate Medical Education Resident Research Award (2015) Investigator to Watch Award (2018) Outstanding Early (Faculty) Career Development Award (2020) Outstanding Early-Stage Investigator Award (2018) As an educator, Dr. Hicks has mentored over 25 students who have presented at conferences, co-authored publications, and secured research grants. His NIH-funded research includes projects on autism biomarkers, breastmilk micro-transcriptomics, and concussion diagnostics. Since joining Penn State in 2015, he has lectured at numerous symposiums including Pediatric Grand Rounds and the Neuroscience Lecture Series. Dr. Hicks leads the Pediatric Research Resources Office and serves as diagnostic thrust leader for Penn State's Center for Biodevices, bridging clinical pediatrics with innovative diagnostic technologies.